AI-driven mutation-proof vaccine developer.
| Date | Round | Amount |
|---|---|---|
| Feb 2024 | Series A Baseimmune, a London AI-vaccine biotech, raised an $11.3M Series A led by MSD Global Health Innovation Fund and IQ Capital. | $11.3M |
| Apr 2021 | Seed London biotech Baseimmune raised GBP685K led by Creator Fund, with Maki VC and Rockmount Seed Investments. | $803K |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.